DRSHF(DRSHF)
DRSHF
No analyst ratings available
No analyst price targets available for DRSHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $283M | $347M | $423M |
| Low | $278M | $313M | $397M |
| High | $287M | $391M | $456M |
| EBITDA Avg | $-17M | $23M | $57M |
| Low | $-20M | $23M | $54M |
| High | $-14M | $24M | $61M |
| EBIT Avg | $-29M | $9M | $40M |
| Low | $-32M | $8M | $37M |
| High | $-26M | $10M | $44M |
| Net Income Avg | $-29M | $6M | $27M |
| Low | $-32M | $5M | $25M |
| High | $-27M | $6M | $29M |
| EPS Avg | $-0.03 | $0.01 | $0.03 |
| Low | $-0.03 | $0.01 | $0.03 |
| High | $-0.03 | $0.01 | $0.03 |
| Analysts (Rev / EPS) | 4 / 1 | 5 / 1 | 1 / 1 |